NextCure, Inc. (NXTC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for NextCure, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.72x | -0.39x | -0.51x | -0.52x | -2.39x | -8.20x |
| P/B Ratio | 1.15x | 0.33x | 0.28x | 0.23x | 0.71x | 1.02x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 13.41x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -108.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -184.2% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -163.6% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -169.0% |
| Liquidity | ||||||
| Current Ratio | 4.14x | 7.50x | 16.38x | 17.97x | 34.48x | 27.89x |
| Quick Ratio | 4.14x | 7.50x | 16.38x | 18.04x | 34.48x | 27.89x |
| Leverage | ||||||
| Debt/Equity | 0.12x | 0.09x | 0.06x | 0.04x | 0.00x | 0.01x |
YoY = year-over-year change. Source: FMP..